Loading...
•
Dec 31, 2022
Progyny Q4 2022 Earnings Report
Reported record quarterly revenue and operating cash flow.
Key Takeaways
Progyny reported a strong fourth quarter in 2022, with revenue growing 68% over the prior year period and a record $51.5 million in operating cash flow. The company's client base has become more diverse, and they anticipate crossing the $1 billion revenue milestone in 2023.
Revenue grew 68% over the prior year period.
Gross margin expanded by 110 basis points.
Generated a record $51.5 million in operating cash flow.
Adjusted EBITDA margin on incremental revenue in 2022 exceeded 20%.
Progyny
Progyny
Progyny Revenue by Segment
Revenue by Segment
Fertility Benefit Services Revenue
CapyFin.comPharmacy Benefit Services Revenue
CapyFin.com Forward Guidance
The Company is providing the following financial guidance for the full year period ending December 31, 2023 and the three-month period ending March 31, 2023:
Positive Outlook
- Revenue is projected to be $1,000 million to $1,030 million, reflecting growth of 27% to 31%
- Net income is projected to be $27.0 million to $32.7 million, or $0.26 to $0.32 per diluted share, on the basis of approximately 103 million assumed weighted-average fully diluted-shares outstanding
- Adjusted EBITDA is projected to be $166.0 million to $174.0 million
- Revenue is projected to be $245.0 million to $250.0 million, reflecting growth of 42% to 45%
- Net income is projected to be $6.8 million to $8.6 million, or $0.07 to $0.08 per diluted share, on the basis of approximately 102 million assumed weighted-average fully diluted-shares outstanding
Revenue & Expenses
Visualization of income flow from segment revenue to net income